Webb13 dec. 2014 · Biotechnology company iBio Inc. recently provided updates at its Annual Meeting for shareholders and attendees on the development progress of IBIO-CFB03 … Webb27 apr. 2015 · About iBio, Inc. iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, …
Improvement Patent Awarded to iBio for IPF And Other Fibrotic...
Webb28 okt. 2014 · Home News New Castle County iBio broadens ties with California biotech company as stock price plunges Webb13 dec. 2014 · iBio, Inc. has released the latest information on the development of IBIO-CFB03, a therapy designed to address significant unmet medical needs for the … holiday light tours nashville tn
iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate …
Webb24 juli 2024 · NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO) (“iBio”), a leader in developing plant-based biopharmaceuticals, announced today that it has entered into a $16 million common stock purchase agreement with Lincoln Park Capital Fund, LLC (“LPC”), a Chicago-based institutional investor. Upon execution … WebbIBIO-CFB03, based on the Company's proprietary gene expression technology, is the Company's lead therapeutic candidate being advanced for IND development Data published in 2012 by Dr. Feghali-Bostwick demonstrate that specific endostatin-derived peptides are useful for both inhibition and reversal of fibrosis in preclinical mouse … Webb7 apr. 2016 · About iBio, Inc. iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, … holiday light tours sacramento